In vitro antimicrobial activity of alpha-melanocyte stimulating hormone against major human pathogen Staphylococcus aureus.
Alpha-melanocyte stimulating hormone (alpha-MSH) is an endogenous anti-inflammatory peptide reported to possess antimicrobial properties, however their role as antibacterial peptides is yet to be established. In the present study, we examined in vitro antibacterial activity of alpha-MSH against S. aureus strain ISP479C and several methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) S. aureus strains. Antibacterial activity was examined by varying several parameters, viz., bacterial cell densities, growth phase, pH, salt concentration, and temperature. Antibacterial activity was also examined in complex biomatrices of rat whole blood, plasma and serum as well as in biofilm form of bacteria. Our results showed that alpha-MSH possessed significant and rapid antibacterial activity against all the studied strains including MRSA (84% strains were killed on exposure to 12 microM of alpha-MSH for 2h). pH change from 7.4 to 4 increased alpha-MSH staphylocidal activity against ISP479C by 21%. Antibacterial activity of alpha-MSH was dependent on bacterial cell density and independent of growth phase. Moreover, antimicrobial activity was retained when alpha-MSH was placed into whole blood, plasma, and serum. Most importantly, alpha-MSH exhibited antibacterial activity against staphylococcal biofilms. Multiple membrane permeabilization assays suggested that membrane damage was, at least in part, a major mechanism of staphylocidal activity of alpha-MSH. Collectively the above findings suggest that alpha-MSH could be a promising candidate of a novel class of antimicrobial agents.
Madhuri
School of Environmental Sciences, Jawaharlal Nehru University, New Delhi, India.
Shireen
Tahsina
T
Venugopal
S K
SK
Ghosh
Dipankar
D
Gadepalli
Ravisekhar
R
Dhawan
Benu
B
Mukhopadhyay
Kasturi
K
D000667:Ampicillin / Q000494:pharmacology; D000818:Animals; D023181:Antimicrobial Cationic Peptides / Q000494:pharmacology; D018441:Biofilms / Q000187:drug effects; D002463:Cell Membrane Permeability / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006096:Gramicidin / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D016106:Methicillin Resistance; D050296:Microbial Viability / Q000187:drug effects*; D009994:Osmolar Concentration; D010949:Plasma / Q000382:microbiology; D051381:Rats; D044967:Serum / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000254:growth & development; D013696:Temperature; D000521:alpha-MSH / Q000494:pharmacology*
D023181:Antimicrobial Cationic Peptides; D006096:Gramicidin; D000521:alpha-MSH; D000667:Ampicillin